Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07146672

Exploratory Study of Super DC Cell Injection in Preventing Recurrence After Radical Surgery for Tumors

Status
Recruiting
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
12 (estimated)
Sponsor
Shanghai Cell Therapy Group Co.,Ltd · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The study is a controlled, open-label exploratory clinical trial.

Conditions

Interventions

TypeNameDescription
BIOLOGICALSuper DC VaccineSuper DC Cell Injection

Timeline

Start date
2025-07-31
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2025-08-28
Last updated
2025-08-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07146672. Inclusion in this directory is not an endorsement.

Exploratory Study of Super DC Cell Injection in Preventing Recurrence After Radical Surgery for Tumors (NCT07146672) · Clinical Trials Directory